Skip to content

Tonghua Dongbao Pharmaceutical Co Ltd Sustainability Reports

Researches, develops, manufactures, and sells pharmaceuticals, specializing in recombinant human insulin and insulin analogs for diabetes treatment, as well as TCM and medical devices

Sector: Manufacturing

Country: China

Exchange: Shanghai Stock Exchange

FIGI: BBG001S88F07

7 reports from 2015 to 2024